Release Date: 15/02/16 09:36 Summary: 650F Notice freeing offer from Defeating Condition - FIRB Price Sensitive: Yes Download Document 306.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%